Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Boceprevir (INN, trade name Victrelis) is a protease inhibitor used to treat hepatitis caused by hepatitis C virus (HCV) genotype 1. It binds to the HCV nonstructural protein 3 active site.
The analysis highlights Clinical trials and Overview as prominent areas in the source structure around Boceprevir.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Boceprevir shows recurring relationship patterns in the source. For example, Boceprevir → April, Copenhagen, European Association, HCV, II, Liver, Study, SVR, The, The SPRINT-1, When Another extracted example is Boceprevir → At, Black, Each, HCV RNA, Important, In, The, The SPRINT-2. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
patients weeks peginterferon ribavirin citation needed plus therapy group received hcv trial 44 genotype victrelis study alfa-2b three peginterferon-ribavirin hepatitis
TTTA extracted 49 structured relationships around Boceprevir. Examples in this analysis include Boceprevir → 3D model (JSmol) → Interactive image and Boceprevir → AHFS/Drugs.com → Consumer Drug Information. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Boceprevir | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Boceprevir | AHFS/Drugs.com | Consumer Drug Information | 1.00 | infobox |
| Boceprevir | ATC code | J05AP03 (WHO) | 1.00 | infobox |
| Boceprevir | CAS Number | 394730-60-0 Y | 1.00 | infobox |
| Boceprevir | ChEMBL | ChEMBL218394 Y | 1.00 | infobox |
| Boceprevir | ChemSpider | 8499830 Y | 1.00 | infobox |
| Boceprevir | CompTox Dashboard (EPA) | DTXSID30960103 | 1.00 | infobox |
| Boceprevir | DrugBank | DB08873 Y | 1.00 | infobox |
| Boceprevir | ECHA InfoCard | 100.226.246 | 1.00 | infobox |
| Boceprevir | Elimination half-life | 3.4 hours | 1.00 | infobox |
| Boceprevir | Formula | C27H45N5O5 | 1.00 | infobox |
| Boceprevir | IUPHAR/BPS | 7876 | 1.00 | infobox |
| Boceprevir | KEGG | D08876 Y | 1.00 | infobox |
| Boceprevir | Legal status | US: ℞-only | 1.00 | infobox |
| Boceprevir | License data | EU EMA: by INN | 1.00 | infobox |
| Boceprevir | License data | US FDA: Boceprevir | 1.00 | infobox |
| Boceprevir | MedlinePlus | a611039 | 1.00 | infobox |
| Boceprevir | Molar mass | 519.687 g·mol−1 | 1.00 | infobox |
| Boceprevir | NIAID ChemDB | 398493 | 1.00 | infobox |
| Boceprevir | Protein binding | 75% | 1.00 | infobox |
| Boceprevir | PubChem CID | 10324367 | 1.00 | infobox |
| Boceprevir | Routes of administration | Oral | 1.00 | infobox |
| Boceprevir | Trade names | Victrelis | 1.00 | infobox |
| Boceprevir | UNII | 89BT58KELH | 1.00 | infobox |
The concept neighborhoods around Boceprevir bring nearby vocabulary together. In this analysis, examples include Weeks, Citation and Group. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Boceprevir, one of the stronger structural bridges in this analysis connects Boceprevir with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Boceprevir to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Clinical trials & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Boceprevir · EN edition · Analysis: TopicsToTalkAbout